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platelets were transfused. At the start of the operation, the
platelet count was 38 × 109/L. The parietal pleura adjacent to
the descending thoracic aorta was already infiltrated by
Aspergillus and also was resected. The cavities resulting from
enucleation were partially filled with collagen sponge impreg-
nated with amphotericin B and then fixed with fibrin glue.
The lung was resutured over the sponge. Histologic studies
and cultures confirmed angioinvasive Aspergillus fumigatus.
The postoperative course was uneventful. Antibiotics and
amphotericin B, as well as granulocyte colony stimulating
factor, were continued. Granulocytes were transfused on days
4 to 8 and the neutrophil count rose to 1.48 × 109/L.
Thereafter, the neutrophil counts continued to rise with stable
engraftment. There was no postoperative bleeding and air leak
was minimal (2 days). The last drain was removed on day 8.
Respiration deteriorated on day 9 with patchy confluent infil-
trates in both lower lobes and some ground-glass pattern
necessitating diuretics and positive-pressure mask respiration,
but not intubation. The patient recovered within 3 days. The
reasons for this deterioration did not become entirely clear.
Transfusion-associated lung injury, post-transplantation inter-
stitial pneumonitis, progressive fungal infection, and fluid
overload were considered as causes. There was no evidence of
graft-versus-host disease. The patient remained afebrile and
was discharged on day 26 after PSCT on a program of intra-
venous amphotericin B. Liposomal amphotericin B was con-
tinued up to day 105. Now, 12 months after PSCT, there is no
evidence of leukemia or recurrent fungal infection.
Comment. This case demonstrates successful combined
surgical and medical treatment of histologically proven inva-
sive pulmonary aspergillosis immediately after bone marrow
transplantation for acute myeloid leukemia. Surgery was per-
formed during the aplastic phase due to conditioning therapy.
Main pillars of treatment in this difficult situation were early
surgery, systemic and local administration of amphotericin B,
and, possibly, granulocyte transfusions during the initial post-
operative phase. Important points to consider are whether the
patient benefited from the operation, as engraftment occurred
soon thereafter, and whether enucleation was preferable to
other types of intervention.
The speed of engraftment and thus the duration of aplasia
could not be predicted at the time of decision-making. The
lesions grew rapidly, a known phenomenon which calls for
therapeutic intervention. The lesions were adjacent to the
hilum of the lobes. Central localization is a known risk factor
for massive hemoptysis,7 which unfortunately seems to occur
quite often during granulocyte recovery1,8 or later, after devel-
opment of cavitary abscess.9 Waiting for leukocyte recovery
therefore did not seem to be a valid option and, like others,10
Invasive pulmonary aspergillosis in patients with neutrope-
nia carries a high mortality. Early resection of localized inva-
sive pulmonary aspergillosis is being advocated by an increas-
ing number of authors,1-5 but definite proof of efficacy is still
missing. Controversy also exists as to whether the lesions
should be eradicated locally (enucleated) or radically (wedge
resection, lobectomy, or even pneumonectomy).6 This ques-
tion is particularly important with hilar lesions.
This article reports a case of successful enucleation with
topical application of amphotericin B in a young patient who
otherwise would have required pneumonectomy.
Clinical summary. A 15-year-old girl with acute myeloid
leukemia FAB M7 underwent induction and consolidation
treatment on a pediatric oncology group protocol and
achieved first complete remission. The leukemia relapsed 9
months later, presenting with complex cytogenetic abnormal-
ities. The girl underwent reinduction treatment with 2-
chlorodeoxyadenosine and idarubicin, but residual blasts per-
sisted in the marrow. She then underwent allogeneic
peripheral stem cell transplantation (PSCT) in second partial
remission with her HLA-identical sister as the donor.
Conditioning was performed with cyclophosphamide 2 × 60
mg/kg, VP-16 30 mg/kg, and 12-Gy total body irradiation in
6 fractions. Thereafter, 5.92 × 106 unmanipulated CD34+
cells per kilogram were transplanted. On day 2 before PSCT
a conventional chest x-ray film showed no abnormalities. On
day 1 after PSCT, her temperature rose to 40.4°C and the con-
centration of C-reactive protein increased to 206 mg/L. She
had no respiratory symptoms or chest pain. The patient had
had aplasia for 12 days. Antifungal therapy with amphotericin
B 1 mg/kg per day was initiated. A computed tomographic
scan of the chest showed two perihilar lesions in the upper and
lower lobes of the left lung, highly suggestive of invasive
aspergillosis (Fig 1). To avoid left pneumonectomy both
lesions were enucleated on day 3 after PSCT. To prevent
bleeding complications during the operation, single donor
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we performed the resection early, 1 day after a computed
tomographic scan confirmed the clinical suspicion.
Pneumonectomy for invasive pulmonary aspergillosis is only
rarely indicated and has been performed in less than 4% of
surgical cases published since 1990.11 Besides creating a sub-
stantial loss of pulmonary function, pneumonectomy also
leaves the patient with a large cavity that may remain perma-
nently contaminated in case of fungal dissemination. Also,
large resections may decrease options for further chemother-
apy because of subsequent damage to pulmonary vessels. As
favorable outcomes have been reported occasionally with
incomplete resections11 and local excision of lung tissue
infarcted by invasive aspergillosis,6 enucleation with topical
administration of amphotericin B was performed. There are
now 3 cases of proven invasive pulmonary aspergillosis (2
published and 1 unpublished) in our own series in which this
procedure was done, and fungal infection was cleared in all 3
cases (1 patient died 11⁄2 years later of a leukemic relapse).
However, we perform enucleations only in exceptional
cases. Early wedge resection and lobectomy continue to be
the standard procedures whenever feasible without severe
loss of lung function.
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Fig 1. Early localized invasive pulmonary aspergillosis in a 15-year old patient with neutropenic leukemia occur-
ring just after bone marrow transplantation. Notice the central location in the hilum of the upper and lower left
lobes. Enucleation with application of a collagen sponge impregnated with amphotericin B was successful, and the
patient is free of fungal infection 12 months after the operation.
